Clinical Trials Browser

Interventional × Skin Neoplasms × epacadostat × Clear all

NCT01604889 2019-03-26

A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma

Phase 1/2 Terminated

Melanoma, Neoplasms, Skin Neoplasms